Related Experiment Videos
Detection of mutagenic activity in urine samples using a new concentration procedure
Mutation Research
|May 1, 1987
Summary
Polygosil C-18 resin is superior for concentrating mutagenic activity from rat urine treated with cyclophosphamide (CP) and its metabolite, nor-nitrogen mustard (NNM). This method allows for better recovery of NNM compared to XAD-2 resin.
Area of Science:
- Toxicology
- Analytical Chemistry
- Pharmacology
Background:
- Cyclophosphamide (CP) is a widely used chemotherapeutic agent.
- Urinary metabolites of CP, such as nor-nitrogen mustard (NNM), can retain mutagenic properties.
- Accurate detection and concentration of these mutagens are crucial for toxicological assessment.
Purpose of the Study:
- To compare the efficacy of Polygosil C-18 and XAD-2 resins for concentrating mutagenic activity in rat urine.
- To determine the optimal resin for recovering cyclophosphamide and its primary urinary metabolite.
Main Methods:
- Urine samples from rats treated with cyclophosphamide were analyzed.
- Mutagenic activity was detected using Salmonella typhimurium tester strain TA1535.
- Separation and concentration of mutagens were performed using Polygosil C-18 and XAD-2 resins, followed by methanol elution.
Main Results:
- Polygosil C-18 resin demonstrated superior performance in concentrating mutagenic activity compared to XAD-2 resin.
- Nor-nitrogen mustard (NNM) was irreversibly bound to XAD-2 resin, preventing its recovery.
- NNM could be effectively recovered after elution with methanol from Polygosil C-18 resin.
- Experiments with varying doses of CP confirmed the better efficacy of Polygosil C-18.
Conclusions:
- Polygosil C-18 resin is the preferred method for concentrating cyclophosphamide and its mutagenic metabolites from rat urine.
- This improved concentration technique enhances the detection and toxicological evaluation of CP-induced mutagenicity.